Synthomycin, liniment 10% 25 g

The active ingredient of the drug is chloramphenicol – a broad spectrum antibiotic with high antibacterial activity against the causative agent of wound infection and various forms of purulent inflammatory processes.< br> < br> Chloramphenicol is a bacteriostatic antibiotic, disrupts protein synthesis in a microbial cell (possessing high lipophilicity, penetrates through the cell membrane of bacteria and reversibly binds to the subunit < br br> < br> < br> 50S subunit of bacterial ribosomes, as a result, the movement of amino acids to the growing peptide chains is delayed, which leads to disruption of peptide bond formation and protein synthesis). < br> < br> < br> Active against most strains of gram-positive and gram-negative microorganisms resistant to penicillin, tetracyclines, sulfonamides. < br> < br> < br> Promotes cleansing and healing of burn wounds and trophic ulcers, accelerates epithelialization.< br> < br> < br> Pharmacokinetics: the degree of absorption into the systemic bloodstream after the use of the drug on the skin, wounds or mucous membranes is unknown.< br>

Indications

bacterial skin infections caused by sensitive microorganisms, incl. infected burns (superficial and delimited deep)
bedsores
trophic ulcers
wounds (II phase of the wound process: absence of pus, necrotic tissue – for liniment devoid of osmotic activity)
boils
cracked nipples in nursing women.

Pharmacological effect

The active ingredient of the drug is chloramphenicol, a broad-spectrum antibiotic with high antibacterial activity against the causative agent of wound infection and various forms of purulent-inflammatory processes.

Chloramphenicol is a bacteriostatic antibiotic that disrupts the process of protein synthesis in the microbial cell (being highly lipophilic, it penetrates the bacterial cell membrane and reversibly binds to the
subunit

50S bacterial ribosomes, as a result of which the movement of amino acids to growing peptide chains is delayed, which leads to disruption of the formation of peptide bonds and protein synthesis).

Active against most strains of gram-positive and gram-negative microorganisms resistant to penicillin, tetracyclines, and sulfonamides.

Promotes cleansing and healing of burn wounds and trophic ulcers, accelerates epithelization.

Pharmacokinetics: the extent of absorption into the systemic circulation after application of the drug to the skin, wounds or mucous membranes is unknown.

Special instructions

During treatment, systematic monitoring of peripheral blood patterns is necessary.

No adverse effects on the fetus have been identified during pregnancy or breastfeeding.

When applied to large surfaces with simultaneous intake of ethanol, the development of disulfiram-like reactions (skin hyperemia, tachycardia, nausea, vomiting, reflex cough, convulsions) is possible.

Active ingredient

Chloramphenicol [D,L]

Composition

Active ingredient:

Chloramphenicol [D,L] (syntomycin) – 100 mg;

Excipients:

Castor oil – 200.0 mg,

Emulsifier No. 1 – 30.0-50.0 mg,

Sorbic acid – 2.0 mg,

Ethanol – 8.1 mg in terms of 96% alcohol,

Carmellose sodium – 18.4 mg in terms of degree of polymerization 450 – 500, water – up to 1 g.

Contraindications

Individual intolerance, suppression of bone marrow hematopoiesis, acute intermittent porphyria, glucose-6-phosphate dehydrogenase deficiency, liver and/or kidney failure, skin diseases (fungal infections, psoriasis, eczema), pregnancy, lactation, neonatal period (up to 4 weeks).

Due to the lack of osmotic activity (base: oil, emulsifier), it is not recommended for use in the first phase of the wound process (profuse suppuration, severe tissue swelling, pain and the presence of necrotic tissue).

With caution

Early childhood, in patients who have previously received treatment with cytotoxic drugs or radiation therapy.

Side Effects

Allergic reactions are possible: skin rash, angioedema.

From the hematopoietic organs:

rarely – reticulocytopenia, leukopenia, granulocytopenia, thrombocytopenia, erythropenia, aplastic anemia, agranulocytosis.

Interaction

Barbiturates accelerate biotransformation, reduce the concentration and duration of the effect.

Reduces the antibacterial effect of penicillins and cephalosporins.

When used simultaneously with erythromycin, clindamycin, lincomycin, a mutual weakening of the effect is observed.

With simultaneous consumption of alcohol, disulfiram-like reactions are possible.

Storage conditions

At a temperature not exceeding 20 °C.

Keep out of reach of children

Shelf life

2 years.

Manufacturer

Nizhpharm JSC, Russia